Aytu Biopharma Inc
NASDAQ:AYTU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
Guaranty Trust Holding Company PLC
LSE:GTCO
|
NG |
|
BASF India Ltd
BSE:500042
|
IN |
|
Caravel Minerals Ltd
ASX:CVV
|
AU |
|
B
|
Biotest AG
XETRA:BIO2
|
DE |
|
Hindalco Industries Ltd
NSE:HINDALCO
|
IN |
|
Rashtriya Chemicals and Fertilizers Ltd
NSE:RCF
|
IN |
Wall St Price Targets
AYTU Price Targets Summary
Aytu Biopharma Inc
According to Wall Street analysts, the average 1-year price target for AYTU is 9.52 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AYTU's stock price target?
Price Target
9.52
USD
According to Wall Street analysts, the average 1-year price target for AYTU is 9.52 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Aytu Biopharma Inc?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Aytu Biopharma Inc?
Projected CAGR
17%
The compound annual growth rate for Operating Income over the next 3 years is 17%.
